Neonatal Hyperbilirubinemia Learning and Decisionmaking Tool
CC:
Neonatal jaundice monitoring
HPI:
Birth Date and Time:
2023
2024
2025
/
1
2
3
4
5
6
7
8
9
10
11
12
/
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
:
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
,
Male
Female
neonate at
___
hours of life,
with the following risk factors:
(Major risk factors)
Gestational age 35 to 37+6/7 weeks
Temperature instability
Lethargy
Hemolytic disease (ABO/Rh incompatibility, hemoglobinopathy, polycythemia)
Acidosis
Sepsis
Asphyxia
Albumin < 3.0g/dL
Glucose-6 Phosphate Deficiency (G6PD)
Sick-appearing neonate
(Minor risk factors)
Breastfeeding
use of oxytocin/diazepam peripartum
ethnicity Asian or Native American
Gestational Diabetes
Group B Streptococcus test positive or unknown
poor feeding
birth trauma e.g. cephalohematoma or instrument delivery
prior sibling with jaundice
Assessment and Plan
Date & Time
Hours of Life
TSB or TcB
Jaundice?
Assessment
Plan
References
Add Row
Calculate
Graphs
References & Credits
TcB = Transcutaneous Bilirubin
TSB = Total Serum Bilirubin
VK Bhutani,
Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns
AAP Guideline:
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Rubaltelli,
Transcutaneous Bilirubin Measurement: A Multicenter Evaluation of a New Device
Teachers and colleagues: Tom Balsbaugh MD, Kay Nelsen MD, Robert Byrd MD and many others
Please send me feedback!
shomirb@shomir.org
Last update September 4, 2014